• DOI:10.1016/j.drugalcdep.2015.08.013
Corpus ID: 19116483

Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.

@article{McRaeClark2015BuspironeTO,
  title={Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.},
  author={A. McRae-Clark and N. Baker and K. Gray and T. Killeen and A. Wagner and K. Brady and C. L. DeVane and Jessica Norton},
  journal={Drug and alcohol dependence},
  year={2015},
  volume={156},
  pages={
          29-37
        }
}

A. McRae-Clark, N. Baker, +5 authors Jessica Norton

Published 2015

Medicine

Drug and alcohol dependence

BACKGROUND The purpose of this study was to evaluate the efficacy of buspirone, a partial 5-HT1A agonist, for treatment of cannabis dependence. METHODS One hundred seventy-five cannabis-dependent adults were randomized to receive either up to 60mg/day of buspirone (n=88) or placebo (n=87) for 12 weeks combined with a brief motivational enhancement therapy intervention and contingency management to encourage study retention. Cannabis use outcomes were assessed via weekly urine cannabinoid… CONTINUE READING

View on PubMed

europepmc.org

Save to Library

Create Alert

Cite

Launch Research Feed